A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.
Aghajanian C, Soignet S, Dizon DS, Pien CS, Adams J, Elliott PJ, Sabbatini P, Miller V, Hensley ML, Pezzulli S, Canales C, Daud A, Spriggs DR.
Aghajanian C, et al.
Clin Cancer Res. 2002 Aug;8(8):2505-11.
Clin Cancer Res. 2002.
PMID: 12171876
Clinical Trial.